Trevor Bedford Profile picture
Jun 22, 2021 12 tweets 4 min read Read on X
An update on genomic surveillance in the US and spread of the Delta variant (PANGO lineage B.1.617.2, Nextstrain clade 21A). At this point, 95% of viruses circulating in the US are "variant" viruses that have been designated as "Variant of Concern" or "Variant of Interest". 1/12 Image
This update mirrors how I was looking at the rise of P.1 across the US in May. 2/12
Here, we can look at frequencies of different variant lineages through time and across states where it's clear that variant viruses and in particular B.1.617.2 viruses are continuing to increase in frequency. 3/12 Image
I'm plotting frequencies on a logit axis as it makes logistic growth appear as a straight line in logit space. This makes it easier to visually compare growth from say 1% to 2% vs 10% to 20%, where both are doublings of frequency. 4/12
We can partition cases reported by @CDCgov based on variant frequency from @GISAID data. Doing so gives the following picture across the US, where it's clear that although B.1.1.7 and P.1 have begun decline, B.1.617.2 is increasing in absolute numbers. 5/12 Image
We see a similar picture across states, again with B.1.617.2 at lower incidence but rising. 6/12 Image
There will be a necessary lag as genomic data comes in (I'm comfortable with estimates 18 days back for US states shown here), but we generally want to know current estimate of variant-specific Rt to assess whether variant sub-epidemics are growing or subsiding. 7/12
Here, @marlinfiggins has come up with a clever Bayesian approach that models the process of observing daily case counts alongside the observation process describing how sequenced genomes are distributed across variants. 8/12
This gives a quantitative estimate of daily Rt across variants and across states. The main assumption is that genomes deposited into GISAID are a decent surveillance sample of the viral population. Due to CDC NS3 surveillance efforts, I believe this is reasonable for the US. 9/12
Here, we see daily Rt estimates for each major variant across states, where it's clear that Rt for non-variant viruses has been consistently below 1, while Rt for B.1.1.7, P.1 and B.1.526 has been drifting downwards since March and is now generally below 1 across states. 10/12 Image
However, Rt for B.1.617.2 is significantly higher and well above 1 in most of the 16 states analyzed. This figure shows Rt at the final timepoint estimated (May 31). 11/12 Image
We know from @PHE_uk that B.1.617.2 is primarily transmitting through the unvaccinated (or partially vaccinated) population. It's difficult to predict the size of a B.1.617.2 epidemic we'll see, but I would expect at least some correlation with regional vaccine coverage. 12/12

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Trevor Bedford

Trevor Bedford Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @trvrb

Dec 5, 2022
Currently, the US is reporting about 54k daily cases of COVID-19 (16 per 100k per capita) and the UK is reporting about 4k (6 per 100k). This seems comfortingly low compared to even this summer's BA.5 wave and let alone last winter's BA.1 wave. Figure from @OurWorldInData. 1/16
However, at this point, nearly all infections will be in individuals with prior immunity from vaccination or infection and this combined with a roll back in testing makes it unclear how to interpret current case counts compared to previous time periods. 2/16
We're interested in the case detection rate or the ratio of underlying new infections compared to reported cases. Throughout much of 2020 and 2021, I had a working estimate of 1 infection in ~3.5 getting reported as a case. 3/16
Read 16 tweets
Aug 16, 2022
Largely through partial immune escape, lineage BA.5 viruses resulted in sizable epidemics throughout much of the world. However, in most countries these epidemics are now beginning to wind down. What do we expect after BA.5? 1/10
Lineage BA.2.75 (aka 'Centaurus') has been high on watch lists due to sustained increase in frequency in India combined with the presence of multiple mutations to spike protein. We now have enough sampled BA.2.75 viruses from outside India to make some initial conclusions. 2/10
If we look at frequency data we see sustained logistic growth of BA.2.75 in India, Japan, Singapore and the US. Critically, in India it is clearly displacing BA.5. 3/10
Read 10 tweets
Aug 3, 2022
Based on the experience in winter 2020/2021, seasonal influence on SARS-CoV-2 transmission is quite clear, but much of the Northern Hemisphere is currently experiencing large summer epidemics driven the spread of evolved BA.5 viruses. 1/11
It's necessarily fraught to try to make predictions of seasonal circulation patterns going forwards, but we can gain some intuition from simple epidemiological models. 2/11
In particular, we can use an SIRS system in which individuals go from Susceptible to Infected to Recovered, and then return to the Susceptible class due to immune waning / antigenic drift of the virus. 3/11
Read 12 tweets
Jul 20, 2022
There seems to be a worry that telling people we've exited the "pandemic phase" will lead to further reduced precautions. As always however, I think it's best not to conduct messaging for intended behavioral effect and just try to make scientifically accurate statements. 1/5
Given vaccination and infection, the US and global population now has widespread immunity to SARS-CoV-2 and deaths per-infection are about 10 times lower than they were pre-immunity in 2020 with a ballpark IFR of 0.05% (though this will vary by immunity and age demographics). 2/5
You can see this reduction in mortality rate in looking at projections of deaths from lagged-cases keyed to early case fatality rate. 3/5
Read 5 tweets
Jun 27, 2022
The @US_FDA VRBPAC committee will be meeting tomorrow to discuss variant-specific COVID-19 vaccines (fda.gov/advisory-commi…). Based on present observations, I would argue that the most important metric to optimize are titers against BA.4/BA.5 viruses. 1/10
We've seen repeated replacement of SARS-CoV-2 variants during 2022, first of Delta by Omicron BA.1 and then by sub-lineages of Omicron, with BA.2 replacing BA.1 and now with BA.4/BA.5 replacing BA.2. 2/10
Viruses have been evolving to be higher fitness through both increases in intrinsic transmissibility (seen in BA.2 vs BA.1) as well as escape from existing population immunity (seen in Omicron vs Delta as well as BA.4/BA.5 vs BA.2). 3/10
Read 10 tweets
Jun 3, 2022
Global monkeypox confirmed and suspected cases compiled by @globaldothealth show initial rapid increase as case-based surveillance comes online, followed by slower continued growth. 1/10
This is data from github.com/globaldothealt… and has had a 7-day smoothing applied and all y-axes are shown on a log scale. 2/10
If we focus on the last 11 days, we can see steady exponential growth in global cases with a ~7.7 day doubling. 3/10
Read 11 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(